A Novel Diphenylthiosemicarbazide Is a Potential Insulin Secretagogue for Anti-Diabetic Agent

• Kenji Sugawara,

  Affiliations Division of Molecular and Metabolic Medicine, Kobe University Graduate School of Medicine, Kobe, Japan, Division of Diabetes and Endocrinology, Kobe University Graduate School of Medicine, Kobe, Japan

  ⨯
• Kohei Honda,

  Affiliation Division of Molecular and Metabolic Medicine, Kobe University Graduate School of Medicine, Kobe, Japan

  ⨯
• Yoshie Reien,

  Affiliation Department of Pharmacology, Graduate School of Medicine, Chiba University, Chiba, Japan

  ⨯
• Norihide Yokoi,

  Affiliation Division of Molecular and Metabolic Medicine, Kobe University Graduate School of Medicine, Kobe, Japan

  ⨯
• Chihiro Seki,

  Affiliation Division of Molecular and Metabolic Medicine, Kobe University Graduate School of Medicine, Kobe, Japan

  ⨯
• Harumi Takahashi,

  Affiliation Division of Molecular and Metabolic Medicine, Kobe University Graduate School of Medicine, Kobe, Japan

  ⨯
• Kohtaro Minami,

  Affiliation Division of Molecular and Metabolic Medicine, Kobe University Graduate School of Medicine, Kobe, Japan

  ⨯
• Ichiro Mori,

  Affiliation Division of Advance Medical Science, Graduate School of Science, Technology and Innovation, Kobe University, Kobe, Japan

  ⨯
• Akio Matsumoto,

  Affiliation Department of Pharmacology, Graduate School of Medicine, Chiba University, Chiba, Japan

  ⨯
• Haruaki Nakaya,

  Affiliation Department of Pharmacology, Graduate School of Medicine, Chiba University, Chiba, Japan

  ⨯
• Susumu Seino

  * E-mail: seino@med.kobe-u.ac.jp

  Affiliation Division of Molecular and Metabolic Medicine, Kobe University Graduate School of Medicine, Kobe, Japan

  ⨯